Stroke

Introduction

Stroke is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Stroke is a medical emergency characterized by the sudden interruption of blood supply to the brain, leading to rapid neuronal death and neurological deficits. It is a leading cause of death and disability worldwide, and shares complex bidirectional relationships with neurodegenerative diseases.

Overview

Stroke, also known as cerebrovascular accident (CVA), occurs when the blood supply to part of the brain is interrupted or severely reduced, depriving brain tissue of oxygen and nutrients. Within minutes, brain cells begin to die, making immediate treatment critical for survival and minimizing permanent damage.

The relationship between stroke and neurodegenerative diseases is bidirectional: neurodegenerative conditions increase stroke risk, while stroke events can accelerate neurodegeneration and increase the risk of developing conditions like vascular dementia and Alzheimer’s disease.

Types of Stroke

Ischemic Stroke

Ischemic strokes account for approximately 87% of all stroke cases and occur when a blood clot blocks or narrows an artery supplying blood to the brain^{1The role of physiotherapists in acute post-stroke neurorehabilitation: qualitative perspectives from clinicians and stroke unit managersPMID 41733307Open reference}.

Mechanisms:

• Thrombosis: Formation of a blood clot within cerebral arteries, often at sites of atherosclerotic plaque

• Embolism: A clot or debris formed elsewhere (typically the heart or carotid arteries) travels through bloodstream to cerebral vessels

• Systemic hypoperfusion: General reduction in blood flow throughout the body, often due to cardiac failure

Risk Factors:

• Atrial fibrillation

• Carotid artery stenosis

• Hypertension

• Diabetes mellitus

• Hyperlipidemia

• Smoking

• Sedentary lifestyle

Brain-Computer Interface Rehabilitation

BCI technology has emerged as a promising approach for post-stroke motor rehabilitation, particularly for restoring upper limb function. ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}

BCI Paradigms for Stroke Rehabilitation

• Motor Imagery BCI: Patients mentally rehearse movements, activating the same neural circuits as physical practice ^{3Motor imagery BCI for stroke rehabilitation (2018)2018 · DOI 10.1088/1741-2552/aac007Open reference}

• P300 BCI: Event-related potentials used for communication and cognitive rehabilitation ^{4Brain-computer communication (2005)2005 · DOI 10.1016/j.clinph.2004.10.004Open reference}

• SSVEP BCI: Steady-state visual evoked potentials for attention-based training ^{5SSVEP-based BCI (2011)2011 · DOI 10.1109/TNSRE.2011.2121060Open reference}

Clinical Evidence

Studies have demonstrated that BCI-assisted rehabilitation can:

• Improve motor function recovery in chronic stroke patients ^{6Brain-machine interface in chronic stroke (2013)2013 · DOI 10.1016/j.clinph.2012.11.031Open reference}

• Enhance neuroplasticity through closed-loop feedback mechanisms ^{7Neuroplasticity and BCI (2010)2010 · DOI 10.4015/S1011147210001023Open reference}

• Enable motor recovery even years after stroke ^{8Long-term stroke recovery (2022)2022 · DOI 10.1038/s41582-022-00656-3Open reference}

Technology Providers

• BCI Rehabilitation: Specialized platforms for motor recovery ^{9BCI Rehabilitation TechnologiesOpen reference}

• ^{10OpenBCI PlatformOpen reference}(/technologies/openbci): Research platforms for developing custom rehabilitation protocols ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}0

• ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}1(/technologies/mindmaze): VR-integrated BCI for immersive rehabilitation ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}2

^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}3: Pichiorri et al., Brain-computer interface in stroke (2015) ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}4: Cervera et al., Motor imagery BCI for stroke rehabilitation (2018) ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}5: Kübler et al., Brain-computer communication (2005) ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}6: Volosyak et al., SSVEP-based BCI (2011) ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}7: Ramos-Murguialday et al., Brain-machine interface in chronic stroke (2013) ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}8: Carabalona et al., Neuroplasticity and BCI (2010) ^{2Brain-computer interface in stroke (2015)2015 · DOI 10.1093/brain/awv086Open reference}9: Buch et al., Long-term stroke recovery (2022) ^{3Motor imagery BCI for stroke rehabilitation (2018)2018 · DOI 10.1088/1741-2552/aac007Open reference}0: BCI Rehabilitation Technologies ^{3Motor imagery BCI for stroke rehabilitation (2018)2018 · DOI 10.1088/1741-2552/aac007Open reference}1: OpenBCI Platform ^{3Motor imagery BCI for stroke rehabilitation (2018)2018 · DOI 10.1088/1741-2552/aac007Open reference}2: MindMaze VR Rehabilitation

Hemorrhagic Stroke

Hemorrhagic strokes occur when a blood vessel in the brain ruptures and bleeds into surrounding tissue, comprising about 13% of strokes^{3Motor imagery BCI for stroke rehabilitation (2018)2018 · DOI 10.1088/1741-2552/aac007Open reference}3.

Subtypes:

• Intracerebral hemorrhage: Bleeding directly into brain tissue

• Subarachnoid hemorrhage: Bleeding into the space between brain and membranes

Common Causes:

• Hypertension (most common cause of intracerebral hemorrhage)

• Cerebral amyloid angiopathy

• Anticoagulant use

• Vascular malformations

• Cerebral aneurysms

Transient Ischemic Attack (TIA)

A TIA is a temporary period of symptoms similar to a stroke, typically lasting less than 5 minutes. Unlike a stroke, a TIA does not cause permanent damage^{3Motor imagery BCI for stroke rehabilitation (2018)2018 · DOI 10.1088/1741-2552/aac007Open reference}4. TIA is a critical warning sign, with about 20% of patients experiencing a stroke within 90 days.

Pathophysiology

Ischemic Cascade

Following cerebral ischemia, a cascade of molecular events leads to irreversible neuronal damage:

1. Energy failure: Within seconds of oxygen deprivation, ATP depletion occurs

2. Excitotoxicity: Glutamate release leads to excessive calcium influx

3. Oxidative stress: Reactive oxygen species accumulate

4. Inflammation: Microglial activation and inflammatory mediator release

5. Apoptosis: Programmed cell death pathways are activated

6. Blood-brain barrier disruption: Permeability increases, contributing to edema

Hemorrhagic Complications

In hemorrhagic stroke, the primary damage results from:

• Direct tissue destruction by the hematoma

• Increased intracranial pressure

• Cerebral edema

• Secondary ischemia from vasospasm (particularly in subarachnoid hemorrhage)

Clinical Presentation

Warning Signs (FAST Assessment)

• Face: Facial drooping or asymmetry

• Arm: Weakness or numbness in one arm

• Speech: Slurred or difficult speech

• Time: Time to call emergency services immediately

Common Neurological Deficits

• Hemiparesis or hemiplegia

• Aphasia (language impairment)

• Visual field defects

• Ataxia and balance problems

• Sensory loss

• Cognitive impairment

• Dysphagia (swallowing difficulty)

Diagnosis

Neuroimaging

• CT scan: Rapidly rules out hemorrhage; within 25 minutes of hospital arrival

• MRI: More sensitive for detecting early ischemic changes

• CT angiography: Identifies vessel occlusions and stenosis

• MR angiography: Detailed visualization of cerebral vessels

• CT perfusion / MRI perfusion: Assesses tissue viability

Additional Diagnostic Tests

• Electrocardiogram (ECG) and cardiac monitoring

• Carotid ultrasound

• Echocardiography

• Blood tests (glucose, cholesterol, coagulation studies)

• Lumbar puncture (in suspected subarachnoid hemorrhage with negative CT)

Treatment

Acute Ischemic Stroke

Thrombolysis:

• Intravenous tissue plasminogen activator (tPA) within 4.5 hours of symptom onset^{3Motor imagery BCI for stroke rehabilitation (2018)2018 · DOI 10.1088/1741-2552/aac007Open reference}5

• Extended window up to 9 hours in select patients with perfusion imaging

Mechanical Thrombectomy:

• For large vessel occlusion (LVO)

• Can be performed up to 24 hours in selected patients

• Significant improvement in functional outcomes when successful^{3Motor imagery BCI for stroke rehabilitation (2018)2018 · DOI 10.1088/1741-2552/aac007Open reference}6

Neuroprotective Agents:

• Currently no proven neuroprotective drugs for clinical use

• Research continues into compounds targeting excitotoxicity, oxidative stress, and inflammation

Acute Hemorrhagic Stroke

• Blood pressure management

• Reversal of anticoagulation (if present)

• Surgical evacuation of hematoma in select cases

• Monitoring and management of intracranial pressure

• Treatment of vasospasm (in subarachnoid hemorrhage)

Secondary Prevention

• Antiplatelet therapy (aspirin, clopidogrel, dual therapy)

• Anticoagulation for cardioembolic stroke (atrial fibrillation)

• Statin therapy for lipid management

• Blood pressure control

• Lifestyle modification

• Carotid endarterectomy or stenting for significant carotid stenosis

Relationship to Neurodegenerative Diseases

Stroke and Alzheimer’s Disease

The relationship between stroke and Alzheimer’s disease is complex and bidirectional:

• Shared vascular risk factors: Hypertension, diabetes, and atherosclerosis are risk factors for both conditions[^6]

• Vascular contributions to AD: Cerebrovascular disease may accelerate Alzheimer’s pathology

• Post-stroke cognitive decline: 25-30% of stroke survivors develop dementia within 5 years

• Mixed pathology: Many patients have both vascular and neurodegenerative pathologies

Stroke and Vascular Dementia

Stroke is the primary cause of vascular dementia, the second most common dementia type after Alzheimer’s disease:

• Multi-infarct dementia: Multiple cortical infarcts leading to progressive cognitive decline

• Strategic infarct dementia: Single critical infarct in key cognitive areas

• Small vessel disease: Subcortical lacunes and white matter lesions

Stroke and Parkinson’s Disease

• Stroke can unmask or worsen parkinsonism

• Vascular parkinsonism results from multiple small vessel infarcts affecting basal ganglia

• Patients with Parkinson’s disease have increased stroke risk

Cerebral Amyloid Angiopathy (CAA)

CAA is a specialized small vessel disease where amyloid deposits in cerebral vessel walls:

• Increases risk of lobar intracerebral hemorrhage

• Associated with Alzheimer’s disease pathology

• Can cause cognitive impairment through microbleeds and white matter changes

Risk Factors

Modifiable Risk Factors

Non-Modifiable Risk Factors

• Age (risk doubles each decade after 55)

• Male sex (higher risk, but women have higher mortality)

• Family history

• Previous stroke or TIA

• Race (higher incidence in African Americans and Hispanics)

• Genetic factors (NOTCH3 for CADASIL, APP/ABCA1 for CAA)

Prevention

Primary Prevention

• Blood pressure control (<130/80 mmHg for most adults)

• Atrial fibrillation management with anticoagulation when appropriate

• Statin therapy for appropriate patients

• Lifestyle modifications

• Smoking cessation

• Moderate alcohol consumption

Secondary Prevention (After TIA or Stroke)

• Aggressive risk factor modification

• Antiplatelet or anticoagulant therapy

• Carotid revascularization for severe stenosis

• Lifestyle changes

• Regular follow-up and monitoring

Prognosis

• Approximately 10% of stroke survivors recover completely

• 40% require minor assistance with activities of daily living

• 25% require major assistance or are unable to live independently

• 30-day mortality: 10-20% for ischemic stroke, 30-50% for hemorrhagic stroke

• Survivors have significantly increased risk of recurrent stroke (3-5% annual risk)

Current Research Directions

Novel Therapeutic Approaches

• Neuroprotective compounds: Targeting excitotoxicity, oxidative stress, and inflammation

• Stem cell therapy: Investigating regenerative approaches

• Endovascular therapy advances: Improving thrombectomy techniques and devices

• Personalized medicine: Genetic and biomarker-guided treatment selection

Biomarker Research

• Blood-based biomarkers for early detection

• Neuroimaging advances (AI-enhanced interpretation)

• Perfusion imaging for treatment selection

Prevention Studies

• Novel anticoagulants for atrial fibrillation

• PCSK9 inhibitors for stroke prevention

• Lifestyle intervention trials

See Also

• Vascular Dementia

• Vascular Cognitive Impairment

• Cerebral Amyloid Angiopathy

• Neurovascular Unit

• Cerebrovascular Disease in Neurodegeneration

• Hypertension and Neurodegeneration

Background

The study of Stroke has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Recent Research (2024-2026)

This section highlights recent publications relevant to this disease.

• The role of physiotherapists in acute post-stroke neurorehabilitation: qualitative perspectives from clinicians and stroke unit managers. (2026 Dec 31) - International journal of qualitative studies on health and well-being

• Mechanisms linking hypertension to cardiovascular and cerebrovascular diseases and their clinical implications: A comprehensive review. (2026 Dec 31) - Clinical and experimental hypertension (New York, N.Y. : 1993)

• SII serves as an independent diagnostic indicator for GDM and is regulated by placental 5-HT/NF-κB signaling. (2026 Dec 31) - Hypertension in pregnancy

• Gut bacteria presence in the brain is increased after ischemic stroke in mice. (2026 Dec 31) - Gut microbes

• Long-term safety and effectiveness of hybrid coronary revascularization compared to conventional revascularization strategies: a systematic review and meta-analysis. (2026 Feb) - Annals of medicine and surgery (2012)

External Links

• American Stroke Association

• National Institute of Neurological Disorders and Stroke - Stroke Information

• World Stroke Organization

• Mayo Clinic - Stroke

• MedlinePlus - Stroke

• NIH - Know Stroke Campaign

Pathway Diagram

The following diagram illustrates key molecular interactions and regulatory relationships for Stroke, derived from the SciDEX knowledge graph.

flowchart TD
    subgraph Risk_Factors["[!] Risk Factors and Pathology"]
        APOE_s["APOE"]
        LDLR_s["LDLR"]
        OCLN_s["OCLN (Occludin)"]
        BBB["BBB Disruption"]
    end

    subgraph Immune_Response["🔵 Immune and Inflammatory"]
        C1Q_s["C1Q Complement"]
        C1QA_s["C1QA"]
        SPI1_s["SPI1/PU.1"]
        INFLAM["Neuroinflammation"]
    end

    subgraph Core["🏥 Stroke Pathophysiology"]
        STROKE["Stroke"]
        ISCHEMIA["Ischemic Injury"]
        EXCITOTOX["Excitotoxicity"]
    end

    subgraph Repair["[ok] Therapeutic Targets"]
        LRP1_s["LRP1"]
        MCU_s["MCU"]
        LETM1_s["LETM1"]
        HSPG2_s["HSPG2/Perlecan"]
    end

    APOE_s -->|"risk factor"| STROKE
    LDLR_s -->|"associated"| STROKE
    OCLN_s -->|"BBB integrity"| BBB
    BBB -->|"disrupted in"| STROKE

    C1Q_s -->|"activates"| INFLAM
    C1QA_s -->|"drives"| INFLAM
    SPI1_s -->|"regulates"| INFLAM
    INFLAM -->|"exacerbates"| STROKE

    STROKE -->|"causes"| ISCHEMIA
    ISCHEMIA -->|"triggers"| EXCITOTOX

    LRP1_s -.->|"clearance receptor"| STROKE
    MCU_s -.->|"therapeutic target"| STROKE
    LETM1_s -.->|"therapeutic target"| STROKE
    HSPG2_s -.->|"vascular repair"| STROKE

    style STROKE fill:#FF6B6B,color:#e0e0e0
    style INFLAM fill:#FFB347
    style MCU_s fill:#90EE90
    style LETM1_s fill:#90EE90
    style LRP1_s fill:#90EE90